624 related articles for article (PubMed ID: 27544072)
41. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
42. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
Bacha MM; Nadeem H; Zaib S; Sarwar S; Imran A; Rahman SU; Ali HS; Arif M; Iqbal J
BMC Chem; 2021 Apr; 15(1):28. PubMed ID: 33906691
[TBL] [Abstract][Full Text] [Related]
43. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
[TBL] [Abstract][Full Text] [Related]
44. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
Steuber H; Heine A; Podjarny A; Klebe G
J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
46. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
[TBL] [Abstract][Full Text] [Related]
47. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
[TBL] [Abstract][Full Text] [Related]
48. Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors.
Verma SK; Thareja S
PLoS One; 2017; 12(4):e0175318. PubMed ID: 28399135
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.
Iqbal Z; Hameed S; Ali S; Tehseen Y; Shahid M; Iqbal J
Eur J Med Chem; 2015 Jun; 98():127-38. PubMed ID: 26005026
[TBL] [Abstract][Full Text] [Related]
50. Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study.
Imran A; Shehzad MT; Shah SJA; Al Adhami T; Laws M; Rahman KM; Alharthy RD; Khan IA; Shafiq Z; Iqbal J
Sci Rep; 2022 Apr; 12(1):5734. PubMed ID: 35388067
[TBL] [Abstract][Full Text] [Related]
51. 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase.
Chen X; Zhang S; Yang Y; Hussain S; He M; Gui D; Ma B; Jing C; Qiao Z; Zhu C; Yu Q
Bioorg Med Chem; 2011 Dec; 19(23):7262-9. PubMed ID: 22036211
[TBL] [Abstract][Full Text] [Related]
52. A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.
Han Z; Hao X; Ma B; Zhu C
Eur J Med Chem; 2016 Oct; 121():308-317. PubMed ID: 27267001
[TBL] [Abstract][Full Text] [Related]
53. Combined
Ibrar A; Khan A; Ali M; Sarwar R; Mehsud S; Farooq U; Halimi SMA; Khan I; Al-Harrasi A
Front Chem; 2018; 6():61. PubMed ID: 29632858
[TBL] [Abstract][Full Text] [Related]
54. Docking and molecular dynamics study on the inhibitory activity of coumarins on aldose reductase.
Wang Z; Ling B; Zhang R; Liu Y
J Phys Chem B; 2008 Aug; 112(32):10033-40. PubMed ID: 18637681
[TBL] [Abstract][Full Text] [Related]
55. New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities.
Salar U; Khan KM; Chigurupati S; Syed S; Vijayabalan S; Wadood A; Riaz M; Ghufran M; Perveen S
Med Chem; 2019; 15(1):87-101. PubMed ID: 30179139
[TBL] [Abstract][Full Text] [Related]
56. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
[TBL] [Abstract][Full Text] [Related]
57. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives.
Kurt BZ; Gazioglu I; Sonmez F; Kucukislamoglu M
Bioorg Chem; 2015 Apr; 59():80-90. PubMed ID: 25706320
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P
Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
